GREG MORRISON: Open Payments
NPI 1952343188 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,800 in 97 payments from 17 companies in 2025. Trend: 2023 $818 · 2024 $1,474 · 2025 $1,800
Food & beverage: $1,536Education: $264
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $387 |
| ABBVIE INC. | 18 | $203 |
| Novartis Pharmaceuticals Corporation | 11 | $194 |
| UCB, Inc. | 9 | $172 |
| Janssen Biotech, Inc. | 3 | $113 |
| Lilly USA, LLC | 6 | $104 |
| GENZYME CORPORATION | 4 | $102 |
| Amgen Inc. | 4 | $76 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| Arcutis Biotherapeutics, Inc. | 4 | $71 |
Products named: COSENTYX, ILUMYA, DUPIXENT, Bimzelx, SKYRIZI, TREMFYA, TALTZ, OTEZLA.
Industry payments across NE — which companies pay providers there.
